Artesunate induces ferroptosis in diffuse large B-cell lymphoma cells by targeting PRDX1 and PRDX2
Abstract Diffuse large B-cell lymphoma (DLBCL), the most prevalent non-Hodgkin lymphoma (NHL), is characterized by rapid growth and an unfavorable prognosis. Artesunate (ART), a derivative of Artemisinin, is a widely recognized antimalarial drug that displays notable antitumor properties across dive...
Saved in:
| Main Authors: | Xiaohui Liu, Liyi Zeng, Jing Liu, Yulun Huang, Hua Yao, Jinman Zhong, Jiewen Tan, Xuenjuan Gao, Dan Xiong, Langxia Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-07-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-025-07822-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PRDX1 knockdown promotes erastin-induced ferroptosis and impedes diffuse large B-cell lymphoma development by inhibiting the MAPK/ERK pathway
by: Chuanming Lin, et al.
Published: (2025-04-01) -
PRDX5 and PRDX6 translocation and oligomerization in bull sperm: a response to cryopreservation-induced oxidative stress
by: Mostek-Majewska Agnieszka, et al.
Published: (2025-01-01) -
RUNX2 isoform II protects cancer cells from ferroptosis and apoptosis by promoting PRDX2 expression in oral squamous cell carcinoma
by: Junjun Huang, et al.
Published: (2025-06-01) -
Therapeutic prospects and potential mechanisms of Prdx6: as a novel target in musculoskeletal disorders
by: Hong Sun, et al.
Published: (2025-04-01) -
Macrophages and macrophage extracellular vesicles confer cancer ferroptosis resistance via PRDX6-mediated mitophagy inhibition
by: Naisheng Zheng, et al.
Published: (2025-10-01)